2022
DOI: 10.1016/j.jacr.2022.05.004
|View full text |Cite
|
Sign up to set email alerts
|

Short-Term Mitigation Steps During the Iohexol Contrast Shortage: A Single Institution’s Approach

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
32
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 19 publications
(32 citation statements)
references
References 2 publications
0
32
0
Order By: Relevance
“…Radiology has seen shortages of helium impacting MRI. The shutdown of the Shanghai contrast manufacturing plant during the 2022 summer due to a COVID lockdown resulted in a global reduction of iodinated contrast for over 2 months with extensive changes in clinical practice ( 32 , 33 ). Much of the supply chain issues are external to hospitals but they will impacted by them.…”
Section: Discussionmentioning
confidence: 99%
“…Radiology has seen shortages of helium impacting MRI. The shutdown of the Shanghai contrast manufacturing plant during the 2022 summer due to a COVID lockdown resulted in a global reduction of iodinated contrast for over 2 months with extensive changes in clinical practice ( 32 , 33 ). Much of the supply chain issues are external to hospitals but they will impacted by them.…”
Section: Discussionmentioning
confidence: 99%
“…[13] Last but not least, we built at least 2 weeks of contrast reserves to provide optimal care for emergency department (ED) patients in case the shortage became protracted and while other strategies to acquire contrast while decreasing waste was put in place. [14][15][16] e task force designed a heat map to identify, prioritize, and assess the feasibility of the action steps. Impact scoring, as shown in [Figure 1], further aided the task force in focusing on high-value action items.…”
Section: Overarching Strategy and Background Analysismentioning
confidence: 99%
“…is further provided us to aggressively reduce the overall daily utilization across the enterprise by around 60-80% [Figure 2]. [5,14] Key strategic initiatives ey were identifying strategies that decreased contrast usage and addressing the high-impact factors initially was the key to navigate the ICM production shortage successfully. Our steps mirrored the strategic actions taken by multiple other institutions and are consistent with ACR recommendations with overarching goals of extending contrast supply run rate and reducing waste.…”
Section: Overarching Strategy and Background Analysismentioning
confidence: 99%
See 1 more Smart Citation
“…A large General Electric facility in Shanghai discontinued manufacture of a water-soluble iodine contrast Omnipaque (iohexol) in April 2022. This has resulted in a significant supply chain disruption of one of the most widely used low-osmolality contrast agents in the diagnostic and interventional radiology field [1]. Although production has now resumed, iodinated contrast is likely to remain scarce until at least July 2022 and due to this shortage, many non-emergency tests are being postponed [2].…”
Section: Introductionmentioning
confidence: 99%